FDA Approves J&J's Akeega for Expanded Use in Prostate CancerF
Continue reading...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer
FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer
Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...




